Literature DB >> 29177410

Relationship of acid-base status with arterial stiffness in community-living elders: the Health ABC Study.

Wei Chen1, Anne B Newman2, Linda F Fried3, Dena E Rifkin4, Michael G Shlipak5, Mark J Sarnak6, Ronit Katz7, Magdalena Madero8, Kalani L Raphael9, David A Bushinsky1, Joachim H Ix4,10.   

Abstract

Background: Animal studies suggest that acidosis protects against arterial calcification, which contributes to arterial stiffness. The goal of this study was to investigate the associations of serum bicarbonate and pH with arterial stiffness in community-living older adults.
Methods: We performed cross-sectional analyses among 1698 well-functioning participants 70-79 years of age. Bicarbonate and pH were measured by arterialized venous blood gas at the point of care. Bicarbonate was categorized into low (<23 mEq/L), normal (23-27.9) and high (≥28). Arterialized venous pH (AVpH) was categorized into tertiles: ≤7.40, >7.40-7.42 and >7.42. Arterial stiffness was evaluated by pulse wave velocity (PWV) and high ankle-brachial index (ABI; >1.3/incompressible). We used linear and logistic regression to evaluate the association of bicarbonate and AVpH with PWV and high ABI, respectively.
Results: The mean age was 76 years and 15% had an estimated glomerular filtration rate (eGFR)  <60 mL/min/1.73 m2. The mean bicarbonate was 25.2 ± 2.1 mEq/L and the mean AVpH was 7.41 ± 0.03. Compared with participants in the normal bicarbonate category, those in the low bicarbonate group had 8.8% higher PWV (P = 0.006) and 1.87 greater odds of high ABI (P = 0.04). However, the associations were not significant after adjusting for eGFR (P = 0.24 and 0.43, respectively). There was no difference in PWV or high ABI across AVpH tertiles. Results were similar in those with and without chronic kidney disease and after excluding participants on diuretics. Conclusions: We did not observe an independent association of bicarbonate or AVpH with arterial stiffness measured by high PWV or ABI in community-living older individuals. Future studies evaluating patients with a greater severity of chronic kidney disease and with more extreme alterations in acid-base status are warranted.

Entities:  

Mesh:

Year:  2018        PMID: 29177410      PMCID: PMC6113643          DOI: 10.1093/ndt/gfx292

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  39 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

Review 3.  Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?

Authors:  D S Leake
Journal:  Atherosclerosis       Date:  1997-03-21       Impact factor: 5.162

4.  Creatinine assay by a reaction-kinetic principle.

Authors:  K Larsen
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

5.  Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study.

Authors:  Kirsten Bibbins-Domingo; Glenn M Chertow; Linda F Fried; Michelle C Odden; Anne B Newman; Stephen B Kritchevsky; Tamara B Harris; Suzanne Satterfield; Steven R Cummings; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2006-07-10

6.  Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study.

Authors:  Manjula Kurella; Glenn M Chertow; Linda F Fried; Steven R Cummings; Tamara Harris; Eleanor Simonsick; Suzanne Satterfield; Hilsa Ayonayon; Kristine Yaffe
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

7.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

8.  Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads.

Authors:  Terence M Doherty; Kamlesh Asotra; Lorraine A Fitzpatrick; Jian-Hua Qiao; Douglas J Wilkin; Robert C Detrano; Colin R Dunstan; Prediman K Shah; Tripathi B Rajavashisth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

9.  Metabolic acidosis-induced hypercalcemia in an azotemic patient with primary hyperparathyroidism.

Authors:  Mandana Rastegar; Barton S Levine; Arnold J Felsenfeld
Journal:  Clin Kidney J       Date:  2014-05-09

10.  Metabolic acidosis and the progression of chronic kidney disease.

Authors:  Wei Chen; Matthew K Abramowitz
Journal:  BMC Nephrol       Date:  2014-04-03       Impact factor: 2.388

View more
  2 in total

1.  Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study.

Authors:  Hyo Jin Kim; Eunjeong Kang; Hyunjin Ryu; Miyeun Han; Kyu-Beck Lee; Yong-Soo Kim; Suah Sung; Curie Ahn; Kook-Hwan Oh
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

2.  Effects of Oral Bicarbonate Supplementation on the Cardiovascular Risk Factors and Serum Nutritional Markers in Non-Dialysed Chronic Kidney Disease Patients.

Authors:  Katarzyna Szczecińska; Małgorzata Wajdlich; Maja Nowicka; Michał Nowicki; Ilona Kurnatowska
Journal:  Medicina (Kaunas)       Date:  2022-04-05       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.